Enhancing Chemotherapy Efficacy in Pten -Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity-Reference-Cited by-同舟云学术

Enhancing Chemotherapy Efficacy in Pten -Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity

Published:2014-10 Issue:1 Volume:9 Page:75-89
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Toso Alberto,Revandkar Ajinkya,Di Mitri Diletta,Guccini Ilaria,Proietti Michele,Sarti Manuela,Pinton Sandra,Zhang Jiangwen,Kalathur Madhuri,Civenni Gianluca,Jarrossay David,Montani Erica,Marini Camilla,Garcia-Escudero Ramon,Scanziani Eugenio,Grassi Fabio,Pandolfi Pier Paolo,Catapano Carlo V.,Alimonti Andrea

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference46 articles.

1. A CXCL1 paracrine network links cancer chemoresistance and metastasis;Acharyya;Cell,2012

2. A complex secretory program orchestrated by the inflammasome controls paracrine senescence;Acosta;Nat. Cell Biol.,2013

3. Roles of STAT3 defined by tissue-specific gene targeting;Akira;Oncogene,2000

4. Subtle variations in Pten dose determine cancer susceptibility;Alimonti;Nat. Genet.,2010

5. CD107a as a functional marker for the identification of natural killer cell activity;Alter;J. Immunol. Methods,2004

Cited by 331 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes;Clinical and Translational Medicine;2024-09

2. Local and systemic impact of adipocyte senescence-associated secretory profile;Current Opinion in Endocrine and Metabolic Research;2024-09

3. Therapy-Induced Senescence: Novel Approaches for Markers Identification;International Journal of Molecular Sciences;2024-08-02

4. Deciphering the predictive value of senescence-related signature in lung adenocarcinoma: Implications for antitumor immunity and immunotherapy efficacy;Heliyon;2024-08

5. CDK4/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells;Journal of Advanced Research;2024-08